Shangxi Xiao

Title: Innovations by Shangxi Xiao in Dentinogenesis Imperfecta Treatment

Introduction

Shangxi Xiao is an accomplished inventor based in Shanghai, China. He has made significant contributions to the field of genetics and dentistry, particularly in the diagnosis and treatment of dentinogenesis imperfecta type II (DGI-II). His innovative work has the potential to improve the lives of individuals affected by this condition.

Latest Patents

Shangxi Xiao holds a patent for a method of diagnosing and treating dentinogenesis imperfecta type II by using the dentin sialophosphoprotein (DSPP) gene and its coded product. The invention outlines a method for diagnosing DGI-II and DGI-II with deafness by detecting variations in the DSPP gene, transcript, and/or protein. This method allows for a comparison with the normal DSPP gene to determine the likelihood of suffering from these conditions. Additionally, the patent includes a pharmaceutical composition for treating DGI-II and/or DGI-II with deafness.

Career Highlights

Shangxi Xiao is affiliated with the Chinese Academy of Sciences, where he conducts research and develops innovative solutions in his field. His work has garnered attention for its potential impact on genetic disorders related to dental health.

Collaborations

Shangxi Xiao has collaborated with notable colleagues, including Xiangyin Kong and Guoping Zhao, to advance research in the area of dentinogenesis imperfecta. Their combined expertise contributes to the development of effective diagnostic and treatment methods.

Conclusion

Shangxi Xiao's contributions to the field of genetics and dentistry through his innovative patent demonstrate his commitment to improving healthcare outcomes for individuals with dentinogenesis imperfecta. His work exemplifies the importance of research and innovation in addressing complex medical conditions.